MENLO VENTURES MANAGEMENT L P
Q1 2026 Form 13-F
MENLO PARK, DELAWARE
CIK 0001911541
· CRD 283999
· Exempt reporting adviser
$326.9M Reported Value Total
Exempt Reporting Adviser
menlovc.com
Source: Form ADV filed 2026-03-31
Reported value
$326.9M
Quarter over quarter
0.0%
Holdings
3
Top-10 concentration
100.0%
Key People
Named on the latest Form 13-F filing — not necessarily an owner
Venky Ganesan
Managing Member of General Partner
Filing Navigation
13F Metrics
Loading 13F Metrics
Q1 2026 13F record
Q1 2026 13F filing summary
| Period of report | March 31, 2026 |
|---|---|
| Filed | May 15, 2026 |
| Form | 13F-HR |
| Reported value | $326.9M |
| Positions | 3 |
| Change in reported value | First reported quarter |
| Top-10 concentration | 100.0% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2026 13F
Filed Nov 6, 2026
|
5 | $240.6M |
|
Q2 2026 13F
Filed Aug 10, 2026
|
3 | $357.4M |
|
Q1 2026 13F
Filed May 15, 2026
|
3 | $326.9M |
Top 3 holdings · Q1 2026
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | CHYM CHIME FINL INC | $326.7M | 99.95% |
| 2 | BRZE BRAZE INC | $131.7K | 0.04% |
| 3 | SNTI SENTI BIOSCIENCES INC | $29.0K | < 0.01% |
Values as reported on the Q1 2026 Form 13F. Every position is in the holdings table below.